Johnson & Johnson

Healthcare

Bayer Resurrects Scrapped Blood-Thinning Drug as Breakthrough Stroke Treatment

Photo via imageBROKER/Joko/Newscom

The trial proved so successful that Bayer plans to reach out to regulators in preparation for submitting the drug candidate for approval.

2 min read

Photo by SiyueSteuber via iStock

Healthcare

Johnson & Johnson Buys Prostate Cancer Treatment-Maker Halda for $3.1 Billion

J&J this year lost its patent exclusivity for Stelara, its longtime top-selling drug that treats psoriasis and inflammatory bowel disease.

2 min read
Photo via Michele Eve Sandberg/Sipa USA/Newscom

Consumer

Kimberly-Clark Takeover Offers $48 Billion of Pain Relief to Tylenol-Maker Kenvue

The deal, expected to close in the second half of 2026, comes as Kenvue’s Tylenol political fight is heating up.

2 min read
Photo via Image courtesy of Genmab, All rights reserved. © 2024 Genmab A/S

Healthcare

Genmab Strikes $8 Billion Deal for Cancer Treatment Maker Merus

BMO analysts said in a note Monday they were “encouraged” that Genmab’s acquisition “could start to spur broader M&A in the sector.”

2 min read

Healthcare

Tylenol-Maker’s Shares Sink amid Autism Scrutiny

Photo via imageBROKER/Marvin Samuel TOLENT/Newscom

Studies exploring whether there’s a connection between Tylenol’s key ingredient acetaminophen and autism have had mixed results.

2 min read

Photo by Marco Verch via CC BY 2.0

Healthcare

Pfizer Built a Covid Empire, But the World Has Moved On

Pfizer’s stock slumped its lowest level in more than 10 years. The world’s moved on from the pandemic, and nobody loves you when you’re down.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.